Motley Fool  Dec 5  Comment 
The expansion of a big pharma partnership sent the stock headed for the clouds.
FierceBiotech  Nov 22  Comment 
AbbVie drops Halozyme formulation of blockbuster Humira after disappointing trial phil Tue, 11/22/2016 - 05:53
GenEng News  Nov 21  Comment 
Abbvie has backed out of a development program inked in June 2015 using Halozyme Therapeutics’ ENHANZE™ platform technology and a tumor necrosis factor-alpha (TNF-alpha) target after target results were not achieved in a Phase I study. The...
SeekingAlpha  Nov 15  Comment 
Motley Fool  Nov 9  Comment 
The results of the general election have investors optimistic about the future of regulations affecting the industry.
Motley Fool  Nov 8  Comment 
Shares of the small-cap biotech fell hard despite producing little news.
Benzinga  Nov 3  Comment 
  Analysts at Piper Jaffray initiated coverage on Theravance Biopharma Inc (NASDAQ: TBPH) with an Overweight rating. The price target for Theravance Biopharma is set to $42. Theravance Biopharma shares closed at $25.10 on...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki